BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 590654)

  • 21. Effects of oral fructose in normal, diabetic, and impaired glucose tolerance subjects.
    Crapo PA; Kolterman OG; Olefsky JM
    Diabetes Care; 1980; 3(5):575-82. PubMed ID: 7002511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of high carbohydrate intake on hyperglycemia, islet function, and plasma lipoproteins in NIDDM.
    Garg A; Grundy SM; Koffler M
    Diabetes Care; 1992 Nov; 15(11):1572-80. PubMed ID: 1468287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of insulin on the exaggerated glucagon response to arginine stimulation in diabetes mellitus.
    Raskin P; Aydin I; Unger RH
    Diabetes; 1976 Mar; 25(3):227-9. PubMed ID: 1254112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of a high-carbohydrate diet on blood glucose, insulin and triglyceride levels in normal and obese subjects and in obese subjects with impaired glucose tolerance.
    Silva ME; Pupo AA; Ursich MJ
    Braz J Med Biol Res; 1987; 20(3-4):339-50. PubMed ID: 3330460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM.
    Dinneen S; Alzaid A; Turk D; Rizza R
    Diabetologia; 1995 Mar; 38(3):337-43. PubMed ID: 7758881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucagon and diabetes. II. Complete suppression of glucagon by insulin in human diabetes.
    Warne GL; Alford FP; Chisholm DJ; Court J
    Clin Endocrinol (Oxf); 1977 Apr; 6(4):277-84. PubMed ID: 862206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetes in remission. Insulin secretory dynamics.
    Park BN; Gleason RE; Soeldner JS
    Diabetes; 1974 Jul; 23(7):616-23. PubMed ID: 4858339
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics.
    Raskin P; Fujita Y; Unger RH
    J Clin Invest; 1975 Nov; 56(5):1132-8. PubMed ID: 1184740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered responsiveness to cortisol, epinephrine, and glucagon in insulin-infused juvenile-onset diabetics. A mechanism for diabetic instability.
    Shamoon H; Hendler R; Sherwin RS
    Diabetes; 1980 Apr; 29(4):284-91. PubMed ID: 6987117
    [No Abstract]   [Full Text] [Related]  

  • 30. Diurnal variation in carbohydrate tolerance to mixed meal in insulin-dependent diabetic adolescents during continuous intravenous insulin infusion (CIVII).
    Rewers M; Dmochowski K; Walczak M
    Endokrynol Pol; 1985; 36(1):1-7. PubMed ID: 4042995
    [No Abstract]   [Full Text] [Related]  

  • 31. The human amylin analog, pramlintide, corrects postprandial hyperglucagonemia in patients with type 1 diabetes.
    Fineman MS; Koda JE; Shen LZ; Strobel SA; Maggs DG; Weyer C; Kolterman OG
    Metabolism; 2002 May; 51(5):636-41. PubMed ID: 11979398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion.
    Müller WA; Faloona GR; Aguilar-Parada E; Unger RH
    N Engl J Med; 1970 Jul; 283(3):109-15. PubMed ID: 4912452
    [No Abstract]   [Full Text] [Related]  

  • 33. [Blood insulin, glucagon and glucose levels in latent diabetes mellitus determined during glucose tolerance test (effect of phenformin)].
    Tikhonova NE
    Ter Arkh; 1982; 54(10):12-6. PubMed ID: 6758166
    [No Abstract]   [Full Text] [Related]  

  • 34. [Ratio of somatostatin-glucagon secretion in diabetes mellitus].
    Kostiuk EP
    Fiziol Zh (1978); 1985; 31(2):195-201. PubMed ID: 2860024
    [No Abstract]   [Full Text] [Related]  

  • 35. Glucagon physiology and pathophysiology.
    Unger RH
    N Engl J Med; 1971 Aug; 285(8):443-9. PubMed ID: 4997492
    [No Abstract]   [Full Text] [Related]  

  • 36. Diurnal patterns of blood glucose, serum free fatty acids, insulin, glucagon and growth hormone in normals and juvenile diabetics.
    Hansen AP; Johansen K
    Diabetologia; 1970 Feb; 6(1):27-33. PubMed ID: 5434734
    [No Abstract]   [Full Text] [Related]  

  • 37. 24-hour studies of the effects of somatostatin on the levels of plasma growth hormone, glucagon, and glucose in normal subjects and juvenile diabetics.
    Christensen SE; Hansen AP; Weeke J; Lundbaek K
    Diabetes; 1978 Mar; 27(3):300-6. PubMed ID: 640235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in glucagon levels after four to five weeks of glucoregulation by portable insulin infusion pumps.
    Raskin P; Pietri A; Unger R
    Diabetes; 1979 Nov; 28(11):1033-5. PubMed ID: 488544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Blood levels of insulin, pancreatic glucagon and growth hormone following intravenous infusion of L-arginine in patients with recently diagnosed juvenile diabetes].
    Lawecki J; Symonides-Lawecka A; Rogala H
    Pol Arch Med Wewn; 1975 Jun; 53(6):541-9. PubMed ID: 1138243
    [No Abstract]   [Full Text] [Related]  

  • 40. Glucose kinetics and splanchnic uptake following mixed meal ingestion in cirrhotic-diabetic subjects.
    Kiwanuka E; Barazzoni R; Tessari P
    Diabetes Nutr Metab; 2001 Dec; 14(6):315-24. PubMed ID: 11853363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.